{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T16:42:55Z","timestamp":1781196175389,"version":"3.54.1"},"reference-count":70,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T00:00:00Z","timestamp":1629331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015829","name":"Ministerstwo Zdrowia","doi-asserted-by":"publisher","award":["SUB.A130.19.021"],"award-info":[{"award-number":["SUB.A130.19.021"]}],"id":[{"id":"10.13039\/501100015829","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Fungi from the Candida genus are widespread commensals and, at the same time, are the leading cause of fungal infections worldwide. For instance, vulvovaginal candidiasis (VVC) affects approximately 75% of women at least once in their lifetime, remaining the second most common gynecological infection. On the contrary, hospital-acquired fungal bloodstream infections (BSIs), although less frequent, are characterized by a high mortality rate. Undoubtedly, the main reason for this situation are virulence factors that these yeast-like fungi can produce, and the ability to form a biofilm is one of the most important of them. Due to the low effectiveness of classic antimycotics against Candida biofilms, an intense search for new drugs capable of eradicating this structure is highly demanded. One of the most promising groups of compounds exhibiting such properties are antimicrobial peptides (AMPs). This study focuses on a comparison of the efficacy of Omiganan and fluconazole alone and in combination against Candida strains isolated from BSIs. The obtained results are consistent with our previous reports on the effectiveness of Omiganan against clinical strains isolated from VVC. This is also the first report on the combinatory application of Omiganan in the context of fungal BSI. The majority of combinations with fluconazole showed an additive effect, as well as a synergistic effect in the range of certain concentrations. Importantly, such effects are visible at concentrations much lower than for those compounds used individually. Potentially, this entails the possibility of limiting the adverse effects (e.g., toxicity) of Omiganan and fluconazole applied in vivo, thus improving the safety profile of this particular antifungal therapy.<\/jats:p>","DOI":"10.3390\/antibiotics10081001","type":"journal-article","created":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T08:44:45Z","timestamp":1629449085000},"page":"1001","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The Antimicrobial Activity of Omiganan Alone and In Combination against Candida Isolated from Vulvovaginal Candidiasis and Bloodstream Infections"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9921-0811","authenticated-orcid":false,"given":"Dawid","family":"\u017byrek","sequence":"first","affiliation":[{"name":"Department of Microbiology, Faculty of Medicine, Wroc\u0142aw Medical University, 50-367 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Wajda","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Faculty of Medicine, Wroc\u0142aw Medical University, 50-367 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1693-484X","authenticated-orcid":false,"given":"Paulina","family":"Czechowicz","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Faculty of Medicine, Wroc\u0142aw Medical University, 50-367 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Nowicka","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Faculty of Medicine, Wroc\u0142aw Medical University, 50-367 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4797-2635","authenticated-orcid":false,"given":"Maciej","family":"Ja\u015bkiewicz","sequence":"additional","affiliation":[{"name":"Department of Inorganic Chemistry, Faculty of Pharmacy, Medical University of Gda\u0144sk, 80-416 Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3230-6878","authenticated-orcid":false,"given":"Damian","family":"Neubauer","sequence":"additional","affiliation":[{"name":"Department of Inorganic Chemistry, Faculty of Pharmacy, Medical University of Gda\u0144sk, 80-416 Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Kamysz","sequence":"additional","affiliation":[{"name":"Department of Inorganic Chemistry, Faculty of Pharmacy, Medical University of Gda\u0144sk, 80-416 Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,8,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1128\/MMBR.67.3.400-428.2003","article-title":"Candida albicans Secreted Aspartyl Proteinases in Virulence and Pathogenesis","volume":"67","author":"Naglik","year":"2003","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_2","first-page":"629","article-title":"Virulence factors of Candida albicans","volume":"66","author":"Staniszewska","year":"2012","journal-title":"Przegl Epidemiol."},{"key":"ref_3","unstructured":"Sidrim, J., J\u00falio, C., and Rocha, M.F.G. (2012). Micologia M\u00e9dica \u00e0 Luz de Autores Conteponr\u00e2neos, Guanabara Koogan."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1128\/CMR.00076-09","article-title":"Candida infections of the genitourinary tract","volume":"23","author":"Achkar","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1001\/jama.291.11.1368","article-title":"Evaluation of Vaginal Complaints","volume":"291","author":"Anderson","year":"2004","journal-title":"J. Am. Med. Assoc."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/S0140-6736(07)60917-9","article-title":"Vulvovaginal candidosis","volume":"369","author":"Sobel","year":"2007","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e339","DOI":"10.1016\/S1473-3099(18)30103-8","article-title":"Global burden of recurrent vulvovaginal candidiasis: A systematic review","volume":"18","author":"Denning","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1080\/14656566.2018.1476490","article-title":"Current treatment options for vulvovaginal candidiasis caused by azole-resistant Candida species","volume":"19","author":"Sobel","year":"2018","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.ajog.2003.11.027","article-title":"Risk factors for recurrent vulvovaginal candidiasis in women receiving maintenance antifungal therapy: Results of a prospective cohort study","volume":"190","author":"Patel","year":"2004","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3109\/1040841X.2015.1091805","article-title":"Vulvovaginal candidiasis: Epidemiology, microbiology and risk factors","volume":"42","author":"Ferreira","year":"2016","journal-title":"Crit. Rev. Microbiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e499","DOI":"10.1111\/j.1439-0507.2010.01965.x","article-title":"Epidemiological survey of vulvovaginal candidosis in Sfax, Tunisia","volume":"54","author":"Amouri","year":"2011","journal-title":"Mycoses"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.bjm.2016.09.006","article-title":"Prevalence of Candida spp. in cervical-vaginal samples and the in vitro susceptibility of isolates","volume":"48","author":"Brandolt","year":"2017","journal-title":"Braz. J. Microbiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00404-017-4465-y","article-title":"Emergence of Candida glabrata in vulvovaginal candidiasis should be attributed to selective pressure or virulence ability?","volume":"296","author":"Fiorini","year":"2017","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1067\/mob.2001.115116","article-title":"Treatment of complicated Candida vaginitis: Comparison of single and sequential doses of fluconazole","volume":"185","author":"Sobel","year":"2001","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/myc.12204","article-title":"Vulvovaginal candidiasis: Species distribution, fluconazole resistance and drug efflux pump gene overexpression","volume":"57","author":"Zhang","year":"2014","journal-title":"Mycoses"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1021\/acs.chemrev.0c00199","article-title":"Antifungal Drug Resistance: Molecular Mechanisms in Candida albicans and beyond","volume":"121","author":"Lee","year":"2021","journal-title":"Chem. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1128\/AAC.01252-16","article-title":"A combination fluorescence assay demonstrates increased efflux pump activity as a resistance mechanism in azole-resistant vaginal Candida albicans isolates","volume":"60","author":"Bhattacharya","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Bhattacharya, S., Sae-Tia, S., and Fries, B.C. (2020). Candidiasis and mechanisms of antifungal resistance. Antibiotics, 9.","DOI":"10.3390\/antibiotics9060312"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"876","DOI":"10.3201\/eid0808.020059","article-title":"Candida and Candidiasis","volume":"8","author":"Brandt","year":"2002","journal-title":"Emerg. Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1099\/jmm.0.46548-0","article-title":"Invasive fungal infections: A review of epidemiology and management options","volume":"55","author":"Enoch","year":"2006","journal-title":"J. Med. Microbiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/jac\/dkm430","article-title":"Management of candidiasis in the intensive care unit","volume":"61","author":"Schelenz","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"O\u2019Brien, S.N., Blijlevens, N.M.A., Mahfouz, T.H., and Anaissie, E.J. (2003). Infections in patients with hematological cancer: Recent developments. Hematol. Am. Soc. Hematol. Educ. Program., 438\u2013472.","DOI":"10.1182\/asheducation-2003.1.438"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.17951\/c.2018.73.1.47-59","article-title":"Diagnosis and treatment of invasive Candida infections\u2014A review article","volume":"73","author":"Sienkiewicz","year":"2019","journal-title":"Ann. Univ. Mariae Curie Sklodowska Sect. C Biol."},{"key":"ref_24","first-page":"231","article-title":"Phenotype and genotype characterization of Candida albicans strains isolated from patients hospitalized at the Children\u2019s Memorial Health Institute","volume":"60","author":"Garczewska","year":"2008","journal-title":"Med. Dosw. Mikrobiol."},{"key":"ref_25","first-page":"57","article-title":"Invasion of host cells by fungi progresses in several phases","volume":"59","year":"2013","journal-title":"Polish Parasitol. Soc."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"ftw018","DOI":"10.1093\/femspd\/ftw018","article-title":"Pathogenesis of Candida albicans biofilm","volume":"74","author":"Tsui","year":"2016","journal-title":"Pathog. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Garipov, M.R., Sabirova, A.E., Pavelyev, R.S., Shtyrlin, N.V., Lisovskaya, S.A., Bondar, O.V., Laikov, A.V., Romanova, J.G., Bogachev, M.I., and Kayumov, A.R. (2020). Targeting pathogenic fungi, bacteria and fungal-bacterial biofilms by newly synthesized quaternary ammonium derivative of pyridoxine and terbinafine with dual action profile. Bioorg. Chem., 104.","DOI":"10.1016\/j.bioorg.2020.104306"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Sharafutdinov, I.S., Ozhegov, G.D., Sabirova, A.E., Novikova, V.V., Lisovskaya, S.A., Khabibrakhmanova, A.M., Kurbangalieva, A.R., Bogachev, M.I., and Kayumov, A.R. (2020). Increasing Susceptibility of Drug-Resistant Candida albicans to Fluconazole and Terbinafine by 2(5H)-Furanone Derivative. Molecules, 25.","DOI":"10.3390\/molecules25030642"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/S0196-9781(01)00500-9","article-title":"Staphylococcal resistance to antimicrobial peptides of mammalian and bacterial origin","volume":"22","author":"Peschel","year":"2001","journal-title":"Peptides"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0165-6147(00)01490-5","article-title":"Reconstructing one of nature\u2019s designs","volume":"21","author":"Zasloff","year":"2000","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1128\/AAC.48.8.3112-3118.2004","article-title":"Omiganan pentahydrochloride (MBI 226), a topical 12-amino-acid cationic peptide: Spectrum of antimicrobial activity and measurements of bactericidal activity","volume":"48","author":"Sader","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e24122","DOI":"10.1002\/pep2.24122","article-title":"Antimicrobial peptides under clinical investigation","volume":"111","author":"Koo","year":"2019","journal-title":"Pept. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2174\/157489106777452638","article-title":"Omiganan Pentahydrochloride in the Front Line of Clinical Applications of Antimicrobial Peptides","volume":"1","author":"Melo","year":"2006","journal-title":"Recent Pat. Antiinfect. Drug Discov."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1007\/s00726-017-2473-7","article-title":"Retro analog concept: Comparative study on physico-chemical and biological properties of selected antimicrobial peptides","volume":"49","author":"Neubauer","year":"2017","journal-title":"Amino Acids"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Rijsbergen, M., Rijneveld, R., Todd, M., Feiss, G.L., Kouwenhoven, S.T.P., Quint, K.D., Alewijk, D.C.J.G., Koning, M.N.C., Klaassen, E.S., and Burggraaf, J. (2019). Results of phase 2 trials exploring the safety and efficacy of omiganan in patients with human papillomavirus-induced genital lesions. Br. J. Clin. Pharmacol.","DOI":"10.1111\/bcp.14181"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/psc.2970","article-title":"Antifungal peptides: A potential new class of antifungals for treating vulvovaginal candidiasis caused by fluconazole-resistant Candida albicans","volume":"23","author":"Ng","year":"2017","journal-title":"J. Pept. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ijantimicag.2009.05.003","article-title":"Antimicrobial and antifungal activities of a novel cationic antimicrobial peptide, omiganan, in experimental skin colonisation models","volume":"34","author":"Rubinchik","year":"2009","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s12602-021-09757-9","article-title":"Anticandidal Activity of Omiganan and Its Retro Analog Alone and in Combination with Fluconazole","volume":"13","author":"Czechowicz","year":"2021","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"ref_39","unstructured":"Clinical and Laboratory Standards Institute (CLSI) (2002). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts, CLSI. Approved Standards-Second Edition, in CLSI Document M27-2A 2002."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/978-1-60327-151-6_7","article-title":"Conditions for optimal Candida biofilm development in microtiter plates","volume":"499","author":"Krom","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Nilius, A.M. (2002). Antimicrobial Pharmacodynamics in Theory and Clinical Practice, Informa Healthcare USA.","DOI":"10.1097\/00024382-200206000-00018"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12602-018-9444-5","article-title":"Antimicrobial activity of selected antimicrobial peptides against planktonic culture and biofilm of Acinetobacter baumannii","volume":"11","author":"Neubauer","year":"2019","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1086\/501795","article-title":"Nosocomial Infections in Combined Medical-Surgical Intensive Care Units in the United States","volume":"21","author":"Richards","year":"2000","journal-title":"Infect. Control. Hosp. Epidemiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1128\/CMR.9.4.499","article-title":"Epidemiology of nosocomial fungal infections","volume":"9","author":"Fridkin","year":"1996","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1574-6976.2011.00278.x","article-title":"Candida glabrata, Candida parapsilosis and Candida tropicalis: Biology, epidemiology, pathogenicity and antifungal resistance","volume":"36","author":"Silva","year":"2012","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.colsurfb.2018.11.011","article-title":"Biofilms and vulvovaginal candidiasis","volume":"174","author":"Gregorio","year":"2019","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1086\/529435","article-title":"Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit","volume":"46","author":"Chow","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/01.CCM.0000201897.78123.44","article-title":"Invasive candidiasis in the intensive care unit","volume":"34","author":"Pappas","year":"2006","journal-title":"Crit. Care Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/13693786.2012.686673","article-title":"Candida albicans and non-Candida albicans fungemia in an institutional hospital during a decade","volume":"51","author":"Parmeland","year":"2013","journal-title":"Med. Mycol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"18026","DOI":"10.1038\/nrdp.2018.26","article-title":"Invasive candidiasis","volume":"4","author":"Pappas","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3109\/13693780802549594","article-title":"Biofilms of non-Candida albicans Candida species: Quantification, structure and matrix composition","volume":"47","author":"Silva","year":"2009","journal-title":"Med. Mycol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3855\/jidc.2623","article-title":"Epidemiology of Candida blood stream infections: Experience of a tertiary care centre in North India","volume":"7","author":"Chander","year":"2013","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Peters, B.M., Yano, J., Noverr, M.C., and Fidel, P.L. (2014). Candida Vaginitis: When Opportunism Knocks, the Host Responds. PLoS Pathog., 10.","DOI":"10.1371\/journal.ppat.1003965"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Robbins, N., Uppuluri, P., Nett, J., Rajendran, R., Ramage, G., Lopez-Ribot, J.L., Andes, D., and Cowen, L.E. (2011). Hsp90 Governs Dispersion and Drug Resistance of Fungal Biofilms. PLoS Pathog., 7.","DOI":"10.1371\/journal.ppat.1002257"},{"key":"ref_55","first-page":"73","article-title":"Grzybicze zaka\u017cenia szpitalne-narastaj\u0105ce zagro\u017cenie","volume":"2","author":"Ciszewski","year":"2014","journal-title":"Nowa Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"293","DOI":"10.5114\/pdia.2013.38358","article-title":"Antifungal agents commonly used in the superficial and mucosal candidiasis treatment: Mode of action and resistance development","volume":"30","author":"Bondaryk","year":"2013","journal-title":"Postep. Dermatol. Alergol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1056\/NEJMoa066906","article-title":"Anidulafungin versus Fluconazole for Invasive Candidiasis","volume":"356","author":"Reboli","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1128\/AAC.00057-14","article-title":"Activities of fluconazole, caspofungin, anidulafungin, and amphotericin b on planktonic and biofilm Candida species determined by microcalorimetry","volume":"58","author":"Maiolo","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_59","first-page":"213","article-title":"Antimicrobial activity of lipopeptides","volume":"57","author":"Czechowicz","year":"2018","journal-title":"Postep. Mikrobiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/142864","article-title":"Antifungal Susceptibility Patterns, In Vitro Production of Virulence Factors, and Evaluation of Diagnostic Modalities for the Speciation of Pathogenic Candida from Blood Stream Infections and Vulvovaginal Candidiasis","volume":"2014","author":"Tellapragada","year":"2014","journal-title":"J. Pathog."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4103\/0255-0857.124300","article-title":"Species distribution and drug susceptibility of Candida in clinical isolates from a tertiary care centre at Indore","volume":"32","author":"Pahwa","year":"2014","journal-title":"Indian J. Med. Microbiol."},{"key":"ref_62","first-page":"869","article-title":"The statement of polish gynecological society experts on the etiology and treatment of recurrent vulvovaginal candidiasis","volume":"82","author":"Tomaszewski","year":"2011","journal-title":"Ginekol. Pol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e01065-17","DOI":"10.1128\/AAC.01065-17","article-title":"Biofilms formed by isolates from recurrent vulvovaginal candidiasis patients are heterogeneous and insensitive to fluconazole","volume":"61","author":"Sherry","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1128\/AAC.01030-07","article-title":"Mechanism-based pharmacokinetic-pharmacodynamic models of in vitro fungistatic and fungicidal effects against Candida albicans","volume":"52","author":"Venisse","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_65","first-page":"29","article-title":"Aktywno\u015b\u0107 przeciwgrzybicza flukonazolu wobec klinicznych szczep\u00f3w Candida albicans oraz innych Candida spp.\u2014Przegl\u0105d bada\u0144 in vitro przeprowadzonych w r\u00f3\u017cnych o\u015brodkach medycznych the antifungal activity of fl uconazole against clinical of the researc","volume":"65","author":"Mertas","year":"2011","journal-title":"Ann. Acad. Med. Silesiensis"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12602-016-9212-3","article-title":"Sequential and Structural Aspects of Antifungal Peptides from Animals, Bacteria and Fungi Based on Bioinformatics Tools","volume":"8","author":"Singh","year":"2016","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/jam.14493","article-title":"The antiproliferative peptide Ctn[15\u201334] is active against multidrug-resistant yeasts Candida albicans and Cryptococcus neoformans","volume":"128","author":"Cavalcante","year":"2020","journal-title":"J. Appl. Microbiol."},{"key":"ref_68","first-page":"220","article-title":"Wp\u0142yw peptyd\u00f3w przeciwdrobnoustrojowych na biofilm Candida The influence of antimicrobial peptides on Candida biofilm","volume":"15","author":"Dawgul","year":"2010","journal-title":"Alerg. Astma Immunol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1139\/cjm-2018-0337","article-title":"The synergistic antifungal effects of sodium phenylbutyrate combined with azoles against Candida albicans via the regulation of the ras\u2013cAMP\u2013PKA signalling pathway and virulence","volume":"65","author":"Sun","year":"2019","journal-title":"Can. J. Microbiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"5193","DOI":"10.1016\/j.bbagen.2013.07.016","article-title":"Mechanism of action of novel synthetic dodecapeptides against Candida albicans","volume":"1830","author":"Maurya","year":"2013","journal-title":"Biochim. Biophys. Acta Gen. Subj."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/10\/8\/1001\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:47:36Z","timestamp":1760165256000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/10\/8\/1001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,19]]},"references-count":70,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["antibiotics10081001"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics10081001","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,19]]}}}